11 min read
Monthly FDA Guidance and Regulatory News Review - September 2026
This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...
Meet Veristat at BIO CHINA International Convention 2025
Discover what makes Veristat a distinguished name in the life sciences industry. Veristat is a scientific-minded global clinical research organization (CRO) and consultancy that integrates full-service clinical trial execution, regulatory consulting, and strategic planning to accelerate the development, approval, and commercialization of groundbreaking therapies worldwide.
Join Veristat at BIOCHINA 2025, China’s largest biotech convention and hub for innovation and collaboration. The event runs from March 13-15, 2025, in Suzhou, featuring advances in cell and gene therapy, antibody drugs, vaccines, small molecules, peptides, and nucleic acids. Schedule a meeting with Veristat and discover how we can assist with your clinical research and regulatory requirements across Asian markets and beyond.
Veristat Attendees:
Delphine Guérin - Business Development Director
Conference Details:
Date: March 13-15, 2025
Location: Suzhou International Expo Center
Schedule a Meeting:
Fill out the form to schedule a meeting with Delphine and explore how Veristat can accelerate your clinical trials, regulatory submissions, and market access strategies toward success..
Learn more about the conference
8 min read
Monthly FDA Guidance and Regulatory News Review - August 2026
Sep 21, 2026 Veristat Blog
This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...